학술논문
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial
Document Type
Article
Author
Siva, S.; Bressel, M.; Hardcastle, N.; Hofman, M.S.; Shaw, M.; Moon, D.; Lawrentschuk, N.; Kron, T.; Wong, L.-M.; Sidhom, M.; Mancuso, P.; Sridharan, S.; Martin, J.; Vanneste, B.G.L.; Davey, R.; Montgomery, R.; Ruben, J.; Foroudi, F.; Brook, N.R.; Higgs, B.; Lin, C.; Wood, S.; Raman, A.; De Abreu Lourenco, R.; Pryor, D.; Chesson, B.; Ali, M.; Chander, S.; Moore, A.; Cook, O.; Eade, T.; Sharma, H.; Ramanathan, M.; Howe, K.; Frewen, H.
Source
In: The Lancet Oncology . (The Lancet Oncology, March 2024, 25(3):308-316)
Subject
Language
English
ISSN
14745488
14702045
14702045